Abstract
The poor prognosis for patients with metastatic osteosarcoma (OS) indicates that new therapeutic options should be explored. Studies with adenoviral-mediated p53 gene transfer have been conducted in many cancer types including cervical, ovarian, prostatic and head and neck tumors. However, limited work has been carried out with pediatric cancers, including OS. Using three viral constructs containing cDNA for wild-type p53, mutant p53 (Cys135Ser) and lacZ, we studied the effect of adenoviral-mediated gene therapy in four OS cell lines: Saos-2 (p53−/−), HOS (R156P), KHOS/NP (R156P) and MNNG (R156P, F270L). We demonstrated that the virus efficiently enters the cells using the β-galactosidase assay. Using the MTT assay, we have shown a dose-dependent decrease in cell viability 72 h post-treatment that occurs with Ad-wtp53 but not with Ad-mutp53. We have also shown that treatment with Ad-wtp53 significantly increases sensitivity of the cell lines to cisplatin and doxorubicin, chemotherapeutic agents commonly used in the treatment of OS. Our results indicate that restoration of wt p53 function in OS cells provides a basis for novel approaches to treatment of this disease.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Link MP, Eilber F . Osteosarcoma. In: Pizzo PA, Poplack DG (eds.), Principles and Practice of Pediatric Oncology, 3rd edn. Lippincott-Raven: Philadelphia, 1997.
Dorfman HD, Czerniak B . Bone cancers. Cancer 1995; 75(Suppl 1): 203–210.
Hahn M, Dormans JP . Primary bone malignancies in children. Curr Opin Pediatr 1996; 8: 71–74.
Kawashima H, Ogose A, Yoshizawa T, Kuwano R, Hotta T, Hatano H et al. Expression of the coxsackievirus and adenovirus receptor in musculoskeletal tumors and mesenchymal tissues: efficacy of adenoviral gene therapy for osteosarcoma. Cancer Sci 2003; 94: 70–75.
Yeh YA, Herenyiova M, Weber G . Quercetin: synergistic action with carboxyamidotriazole in human breast carcinoma cells. Life Sci 1995; 57: 1285–1292.
Chang EH, Pirollo KF, Bouker KB . Tp53 gene therapy: a key to modulating resistance to anticancer therapies? Mol Med Today 2000; 6: 358–364.
Swisher SG, Roth JA . Clinical update of Ad-p53 gene therapy for lung cancer. Surg Oncol Clin N Am 2002; 11: 521–535.
Gu W, Ogose A, Kawashima H, Ito M, Ito T, Matsuba A et al. High-level expression of the coxsackievirus and adenovirus receptor messenger RNA in osteosarcoma, Ewing's sarcoma, and benign neurogenic tumors among musculoskeletal tumors. Clin Cancer Res 2004; 10: 3831–3838.
Graat HC, Wuisman PI, van Beusechem VW, Carette JE, Gerritsen WR, Bras J et al. Coxsackievirus and adenovirus receptor expression on primary osteosarcoma specimens and implications for gene therapy with recombinant adenoviruses. Clin Cancer Res 2005; 11: 2445–2447.
Acknowledgements
HG is supported by funds from the Canadian Institutes of Health Research. MG, MK and NP were funded through studentships of the Ontario Student Opportunity Trust Fund – Hospital for Sick Children Foundation Student Scholarship Program. AN is supported by a Research Scientist award from the Kids Cancer Care Foundation of Alberta. This work was supported in part by a Seed Grant of the Research Institute, The Hospital for Sick Children, the Andrew Mizzoni Cancer Research Fund, and the Harry and Hanna Fisher Research Fund.
Author information
Authors and Affiliations
Corresponding author
Additional information
Conflict of interest statement
None declared.
Rights and permissions
About this article
Cite this article
Ganjavi, H., Gee, M., Narendran, A. et al. Adenovirus-mediated p53 gene therapy in osteosarcoma cell lines: sensitization to cisplatin and doxorubicin. Cancer Gene Ther 13, 415–419 (2006). https://doi.org/10.1038/sj.cgt.7700909
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.cgt.7700909
Keywords
This article is cited by
-
Verteporfin disrupts multiple steps of autophagy and regulates p53 to sensitize osteosarcoma cells
Cancer Cell International (2021)
-
Drug delivery nanocarriers and recent advances ventured to improve therapeutic efficacy against osteosarcoma: an overview
Journal of the Egyptian National Cancer Institute (2021)
-
Checkpoint kinase inhibitor AZD7762 enhance cisplatin-induced apoptosis in osteosarcoma cells
Cancer Cell International (2019)
-
Distinct activity of the bone-targeted gallium compound KP46 against osteosarcoma cells - synergism with autophagy inhibition
Journal of Experimental & Clinical Cancer Research (2017)
-
p53 overexpression increases chemosensitivity in multidrug-resistant osteosarcoma cell lines
Cancer Chemotherapy and Pharmacology (2016)